CAJ | 학술논문

介入方式治疗肝癌以创伤小、局部作用明显等优势成为非手术治疗肝癌的首选治疗方式。但因药物疗效、肝癌的生物学特性等原因，其疗效不尽如人意。中药与介入手段结合治疗肝癌的研究越来越受到重视。从治疗方式的角度，回顾了近十年来中药结合介入手段治疗肝癌动物实验及临床研究进展，指出中药结合介入手段治疗原发性肝癌具有独特优势。
개입방식치료간암이창상소、국부작용명현등우세성위비수술치료간암적수선치료방식。단인약물료효、간암적생물학특성등원인，기료효불진여인의。중약여개입수단결합치료간암적연구월래월수도중시。종치료방식적각도，회고료근십년래중약결합개입수단치료간암동물실험급림상연구진전，지출중약결합개입수단치료원발성간암구유독특우세。
Interventional therapy has become the first choice of non-surgical treatment for hepatocellular carcinoma (HCC)due to its ad-vantages such as little trauma and marked local effect.However,the clinical efficiency is less than expected.One of the possibilities is the resistance of cancer cells to anti -cancer drugs.Increasing attention has been paid to the combination of traditional Chinese medicine (TCM)and interventional therapy in HCC treatment.This paper reviews the progress in TCM combined with interventional therapy for HCC at animal experiment and clinical study levels in recent ten years.It is pointed out that the combination therapy with TCM and intervention for HCC has a unique advantage.